Skip to content

Clinical trials

Postoperative Complications trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Postoperative Complications Country / region: Spain Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20114
20143
20151
20164
20178
20187
20199
20205
20217
20225
20232
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Unknown status14
Recruiting10
Not yet recruiting2
Active, not recruiting1
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grupo Español de Rehabilitación Multimodal6
Hospital Universitari de Bellvitge4
Hospital Universitario de Gran Canaria Doctor Negrín4
Fundación para la Investigación del Hospital Clínico de Valencia3
Hospital Clinic of Barcelona3
Hospital Universitari Vall d'Hebron Research Institute3
Francisco Andres de la Gala2
Hospital Universitario La Fe2
Puerta de Hierro University Hospital2
University of Valencia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Postoperative Complications69
Obesity, Morbid4
COVID-193
Intraoperative Complications3
Stomach Neoplasms3
Surgical Wound Infection3
Body Temperature Changes2
Colonic Neoplasms2
Esophageal Neoplasms2
Hypothermia2

Trials

Showing 26 to 50 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.